The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Aspirin and colorectal cancer: the promise of precision chemoprevention
Open accessAbstract
Aspirin (acetylsalicylic acid) has become one of the most commonly used drugs, given its role as an analgesic, antipyretic and agent for cardiovascular prophylaxis. Several decades of research have provided considerable evidence demonstrating its potential for the prevention of cancer, particularly colorectal cancer. Broader clinical recommendations for aspirin-based chemoprevention strategies have recently been established; however, given the known hazards of long-term aspirin use, larger-scale adoption of an aspirin chemoprevention strategy is likely to require improved identification of individuals for whom the protective benefits outweigh the harms. Such a precision medicine approach may emerge through further clarification of aspirin's mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021735 · Cited by 1,416
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
Farrell, B., Godwin, J., Richards, S., & Warlow, C. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.12.1044 · Cited by 1,203
Polyamines and cancer: old molecules, new understanding
Gerner, E. W., & Meyskens, F. L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1454 · Cited by 1,159
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
Self-citationRothwell, P. M., Price, J. F., Fowkes, F. G. R., Zanchetti, A., Roncaglioni, M. C., Tognoni, G., Lee, R., Belch, J. F., Wilson, M., Mehta, Z., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61720-0 · Cited by 839
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
the CORGI Consortium, Tomlinson, I., Webb, E., Carvajal-Carmona, L., Broderick, P., Kemp, Z., Spain, S., Penegar, S., Chandler, I., Gorman, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2085 · Cited by 808
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 785
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
Self-citation(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Casero, R. A., & Marton, L. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2243 · Cited by 751
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
Zanke, B. W., Greenwood, C. M., Rangrej, J., Kustra, R., Tenesa, A., Farrington, S. M., Prendergast, J., Olschwang, S., Chiang, T., Crowdy, E., et al. (2007) · Nature Genetics · doi:10.1038/ng2089 · Cited by 724
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
Goessling, W., North, T. E., Loewer, S., Lord, A. M., Lee, S., Stoick-Cooper, C. L., Weidinger, G., Puder, M., Daley, G. Q., Moon, R. T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.015 · Cited by 699
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
Derry, S. (2000) · BMJ · doi:10.1136/bmj.321.7270.1183 · Cited by 677
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
Pomerantz, M. M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M. P., Doddapaneni, H., Beckwith, C. A., Chan, J. A., Hills, A., Davis, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.403 · Cited by 663
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Prophylactic aspirin and risk of peptic ulcer bleeding
Weil, J., Colin-Jones, D., Langman, M., Lawson, D., Logan, R., Murphy, M., Rawlins, M., Vessey, M., & Wainwright, P. (1995) · BMJ · doi:10.1136/bmj.310.6983.827 · Cited by 568
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, A. T. (2009) · JAMA · doi:10.1001/jama.2009.1112 · Cited by 557
Self-citationNon-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 517
The serrated pathway to colorectal carcinoma: current concepts and challenges
Bettington, M., Walker, N., Clouston, A., Brown, I., Leggett, B., & Whitehall, V. (2013) · Histopathology · doi:10.1111/his.12055 · Cited by 502
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
The role of aspirin in cancer prevention
Thun, M. J., Jacobs, E. J., & Patrono, C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.199 · Cited by 481
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Cole, B. F., Logan, R. F., Halabi, S., Benamouzig, R., Sandler, R. S., Grainge, M. J., Chaussade, S., & Baron, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn485 · Cited by 476
McQuaid, K. R., & Laine, L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.039 · Cited by 409
Gupta, R. A., Tan, J., Krause, W. F., Geraci, M. W., Willson, T. M., Dey, S. K., & DuBois, R. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13275 · Cited by 401
Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
Logan, R. F. A., Grainge, M. J., Shepherd, V. C., Armitage, N. C., & Muir, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.014 · Cited by 398
Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., & Chaussade, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00887-4 · Cited by 395
A common genetic risk factor for colorectal and prostate cancer
Haiman, C. A., Le Marchand, L., Yamamato, J., Stram, D. O., Sheng, X., Kolonel, L. N., Wu, A. H., Reich, D., & Henderson, B. E. (2007) · Nature Genetics · doi:10.1038/ng2098 · Cited by 365
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Kune, G. A., Kune, S., & Watson, L. F. (1988) · PubMed · Cited by 352
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Baggish, J. S., Bhatt, D. L., & Topol, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.049 · Cited by 344
Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Walsh Vockley, C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323658 · Cited by 344
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Cook, N. R., Lee, I.-M., Zhang, S. M., Moorthy, M. V., & Buring, J. E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00002 · Cited by 315
Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
Burn, J., Bishop, D. T., Mecklin, J.-P., Macrae, F., Möslein, G., Olschwang, S., Bisgaard, M.-L., Ramesar, R., Eccles, D., Maher, E. R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801297 · Cited by 300
Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study
Sturmer, T., Glynn, R. J., Lee, I.-M., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-9-199805010-00003 · Cited by 294
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
Roderick, P., Wilkes, H., & Meade, T. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb05689.x · Cited by 293
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Din, F. V. N., Theodoratou, E., Farrington, S. M., Tenesa, A., Barnetson, R. A., Cetnarskyj, R., Stark, L., Porteous, M. E., Campbell, H., & Dunlop, M. G. (2010) · Gut · doi:10.1136/gut.2009.203000 · Cited by 284
Fedirko, V., Bradshaw, P. T., Figueiredo, J. C., Sandler, R. S., Barry, E. L., Ahnen, D. J., Milne, G. L., Bresalier, R. S., & Baron, J. A. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0212 · Cited by 278
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
Chan, A. T., Arber, N., Burn, J., Chia, W. K., Elwood, P., Hull, M. A., Logan, R. F., Rothwell, P. M., Schrör, K., & Baron, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0391 · Cited by 276
Self-citationGupta, R. A., Wang, D., Katkuri, S., Wang, H., Dey, S. K., & DuBois, R. N. (2004) · Nature Medicine · doi:10.1038/nm993 · Cited by 275
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh, S., & Thomas, G. A. (1994) · Gut · doi:10.1136/gut.35.5.675 · Cited by 266
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Myung, S.-J., Rerko, R. M., Yan, M., Platzer, P., Guda, K., Dotson, A., Lawrence, E., Dannenberg, A. J., Lovgren, A. K., Luo, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603235103 · Cited by 264
Breit, S. N., Johnen, H., Cook, A. D., Tsai, V. W. W., Mohammad, M. G., Kuffner, T., Zhang, H. P., Marquis, C. P., Jiang, L., Lockwood, G., et al. (2011) · Growth Factors · doi:10.3109/08977194.2011.607137 · Cited by 247
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs
Patrignani, P., & Patrono, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.016 · Cited by 239
Aspirin: A Historical and Contemporary Therapeutic Overview
Fuster, V., & Sweeny, J. M. (2011) · Circulation · doi:10.1161/circulationaha.110.963843 · Cited by 238
Domingo, E., Church, D. N., Sieber, O., Ramamoorthy, R., Yanagisawa, Y., Johnstone, E., Davidson, B., Kerr, D. J., Tomlinson, I. P. M., & Midgley, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.0322 · Cited by 210
Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
Nan, H., Hutter, C. M., Lin, Y., Jacobs, E. J., Ulrich, C. M., White, E., Baron, J. A., Berndt, S. I., Brenner, H., Butterbach, K., et al. (2015) · JAMA · doi:10.1001/jama.2015.1815 · Cited by 204
Self-citationMartínez, M. E., O'Brien, T. G., Fultz, K. E., Babbar, N., Yerushalmi, H., Qu, N., Guo, Y., Boorman, D., Einspahr, J., Alberts, D. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332465100 · Cited by 196
The evolution of colorectal carcinoma
Morson, B. C. (1984) · Clinical Radiology · doi:10.1016/s0009-9260(84)80033-1 · Cited by 193
Serrated neoplasia—role in colorectal carcinogenesis and clinical implications
IJspeert, J. E. G., Vermeulen, L., Meijer, G. A., & Dekker, E. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.73 · Cited by 190
Abraham, N. S., Hlatky, M. A., Antman, E. M., Bhatt, D. L., Bjorkman, D. J., Clark, C. B., Furberg, C. D., Johnson, D. A., Kahi, C. J., Laine, L., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.445 · Cited by 179
Murphey, L. J., Williams, M. K., Sanchez, S. C., Byrne, L. M., Csiki, I., Oates, J. A., Johnson, D. H., & Morrow, J. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.08.019 · Cited by 169
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
Self-citationAspirin for the prevention of colorectal cancer
García‐Albéniz, X., & Chan, A. T. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.015 · Cited by 162
Self-citationCoyle, C., Cafferty, F. H., Rowley, S., MacKenzie, M., Berkman, L., Gupta, S., Pramesh, C. S., Gilbert, D., Kynaston, H., Cameron, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.10.004 · Cited by 161
Friis, S., Riis, A. H., Erichsen, R., Baron, J. A., & Sørensen, H. T. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0039 · Cited by 159
Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A
Bos, C. L., Kodach, L. L., van den Brink, G. R., Diks, S. H., van Santen, M. M., Richel, D. J., Peppelenbosch, M. P., & Hardwick, J. C. H. (2006) · Oncogene · doi:10.1038/sj.onc.1209658 · Cited by 156
The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
Wang, X., Baek, S. J., & Eling, T. E. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.025 · Cited by 154
Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis
Lanas, Á., Wu, P., Medin, J., & Mills, E. J. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.05.020 · Cited by 153
Li, P., Wu, H., Zhang, H., Shi, Y., Xu, J., Ye, Y., Xia, D., Yang, J. J., Cai, J., & Wu, Y. (2014) · Gut · doi:10.1136/gutjnl-2014-308260 · Cited by 144
Dixon, D. A., Tolley, N. D., Bemis–Standoli, K., Martinez, M. L., Weyrich, A. S., Morrow, J. D., Prescott, S. M., & Zimmerman, G. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27209 · Cited by 141
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
Ng, K., Meyerhardt, J. A., Chan, A. T., Sato, K., Chan, J. A.-W., Niedzwiecki, D., Saltz, L. B., Mayer, R. J., Benson, A. B., Schaefer, P., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju345 · Cited by 141
Self-citationU.S. Preventive Services Task Force* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00008 · Cited by 140
Ma, X., Aoki, T., Tsuruyama, T., & Narumiya, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0125 · Cited by 139
Chan, A. T., Ogino, S., Giovannucci, E. L., & Fuchs, C. S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.11.041 · Cited by 135
Self-citationMicrosomal glutathione transferase 1: mechanism and functional roles
Morgenstern, R., Zhang, J., & Johansson, K. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.558511 · Cited by 131
Ishikawa, H., Mutoh, M., Suzuki, S., Tokudome, S., Saida, Y., Abe, T., Okamura, S., Tajika, M., Joh, T., Tanaka, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305827 · Cited by 131
LMO3 Interacts with Neuronal Transcription Factor, HEN2, and Acts as an Oncogene in Neuroblastoma
Aoyama, M., Ozaki, T., Inuzuka, H., Tomotsune, D., Hirato, J., Okamoto, Y., Tokita, H., Ohira, M., & Nakagawara, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4630 · Cited by 115
Fink, S. P., Yamauchi, M., Nishihara, R., Jung, S., Kuchiba, A., Wu, K., Cho, E., Giovannucci, E. L., Fuchs, C. S., Ogino, S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008481 · Cited by 113
Self-citationExpression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
Reimers, M. S., Bastiaannet, E., Langley, R. E., van Eijk, R., van Vlierberghe, R. L. P., Lemmens, V. E. P. P., van Herk‐Sukel, M. P. P., van Wezel, T., Fodde, R., Kuppen, P. J. K., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.511 · Cited by 107
Yan, M., Myung, S., Fink, S. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902367106 · Cited by 102
Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia
Dixon, D. A., Blanco, F. F., Bruno, A., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_2 · Cited by 101
A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer
Mehta, R. S., Song, M., Bezawada, N., Wu, K., García‐Albéniz, X., Morikawa, T., Fuchs, C. S., Ogino, S., Giovannucci, E. L., & Chan, A. T. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju016 · Cited by 98
Self-citationThe role of PGE2 in intestinal inflammation and tumorigenesis
Montrose, D. C., Nakanishi, M., Murphy, R. C., Zarini, S., McAleer, J. P., Vella, A. T., & Rosenberg, D. W. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.10.002 · Cited by 97
Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer
Kwon, Y.-J., Lee, S. J., Koh, J. S., Kim, S., Lee, H. W., Kang, M. C., Bae, J. B., Kim, Y.-J., & Park, J. H. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182307f62 · Cited by 93
Prospective Study of Urinary Prostaglandin E2 Metabolite and Colorectal Cancer Risk
Cai, Q., Gao, Y.-T., Chow, W., Shu, X., Yang, G., Ji, B., Wen, W., Rothman, N., Li, H. L., Morrow, J. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4931 · Cited by 93
mPGES-1 as a target for cancer suppression
Nakanishi, M., Gokhale, V. M., Meuillet, E. J., & Rosenberg, D. W. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.006 · Cited by 87
Johnson, J. C., Schmidt, C. R., Shrubsole, M. J., Billheimer, D. D., Joshi, P., Morrow, J. D., Heslin, M. J., Washington, M. K., Ness, R. M., Zheng, W., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.07.015 · Cited by 87
Combination Chemoprevention for Colon Cancer Targeting Polyamine Synthesis and Inflammation
Gerner, E. W., & Meyskens, F. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2235 · Cited by 86
Gala, M. K., & Chan, A. T. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0877 · Cited by 85
Self-citationThorat, M. A., & Cuzick, J. M. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9971-7 · Cited by 82
Schrör, K. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.10.016 · Cited by 80
Aspirin and Colorectal Cancer: Back to the Future
Tougeron, D., Sha, D., Manthravadi, S., & Sinicrope, F. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2563 · Cited by 73
Nan, H., Morikawa, T., Suuriniemi, M., Imamura, Y., Werner, L. L., Kuchiba, A., Yamauchi, M., Hunter, D. J., Kraft, P. L., Giovannucci, E. L., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt331 · Cited by 72
Self-citationCyclooxygenase-2: How good is it as a target for cancer chemoprevention?
Hull, M. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.013 · Cited by 70
Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial
Pommergaard, H., Burcharth, J., Rosenberg, J., & Raskov, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.09.010 · Cited by 70
Roy, H. K., Turzhitsky, V. M., Kim, Y., Goldberg, M. J., Watson, P. A., Rogers, J. D., Gomes, A., Kromine, A., Brand, R. E., Jameel, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4780 · Cited by 65
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men
Song, M., Wu, K., Ogino, S., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.172 · Cited by 64
Self-citationΚακούρου, Α., Koutsioumpa, C., López, D. S., Hoffman–Bolton, J., Bradwin, G., Rifai, N., Helzlsouer, K. J., Platz, E. A., & Tsilidis, K. K. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0641-1 · Cited by 60
Ouyang, N., Williams, J. L., & Rigas, B. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi221 · Cited by 60
Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma
Shrubsole, M. J., Cai, Q., Wen, W., Milne, G. L., Smalley, W. E., Chen, Z., Ness, R. M., & Zheng, W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0426 · Cited by 53
High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.
Elzagheid, A. I., Emaetig, F. M., Al-Kikhia, L., Buhmeida, A. S., Syrjänen, K. J., El-Faitori, O., Latto, M., Collan, Y. U., & Pyrhönen, S. O. (2013) · PubMed · Cited by 52
McGreavey, L., Turner, F., Smith, G. C., Boylan, K., Bishop, D. T., Forman, D., Wolf, C. R., & Barrett, J. H. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000174786.85238.63 · Cited by 51
Kothari, N., Kim, R. D., Jorissen, R. N., Desai, J., Tie, J., Wong, H., Faragher, I. G., Jones, I. T., Day, F. L., Li, S., et al. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.990158 · Cited by 51
Hubner, R. A., Muir, K. R., Liu, J., Logan, R. F., Grainge, M. J., & Houlston, R. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4599 · Cited by 49
Barry, E. L., Baron, J. A., Bhat, S., Grau, M. V., Burke, C. A., Sandler, R. S., Ahnen, D. J., Haile, R. W., & O’Brien, T. G. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj398 · Cited by 49
Urinary PGE-M: A Promising Cancer Biomarker
Wang, D., & DuBois, R. N. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0153 · Cited by 47
Bezawada, N., Song, M., Wu, K., Mehta, R. S., Milne, G. L., Ogino, S., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0120 · Cited by 44
Self-citationBarry, E. L., Sansbury, L. B., Grau, M. V., Ali, I., Tsang, S. X., Munroe, D. J., Ahnen, D. J., Sandler, R. S., Saibil, F. G., Gui, J., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0363 · Cited by 44
Hull, M. A., Sandell, A. C., Montgomery, A. A., Logan, R. F., Clifford, G. M., Rees, C. J., Loadman, P. M., & Whitham, D. (2013) · Trials · doi:10.1186/1745-6215-14-237 · Cited by 43
Ye, X., Wang, J., Shi, W.-T., & He, J. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.481 · Cited by 39
Thompson, C. L., Plummer, S. J., Merkulova, A. A., Cheng, I. C., Tucker, T. C., Casey, G., & Li, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2240 · Cited by 37
Roy, H. K., Turzhitsky, V. M., Wali, R. K., Radosevich, A. J., Jovanovic, B., Della’Zanna, G., Umar, A., Rubin, D. T., Goldberg, M. J., Bianchi, L. K., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309996 · Cited by 35
Location of Inhibitor Binding Sites in the Human Inducible Prostaglandin E Synthase, MPGES1
Prage, E. B., Pawelzik, S., Busenlehner, L. S., Kim, K.-H., Morgenstern, R., Jakobsson, P., & Armstrong, R. N. (2011) · Biochemistry · doi:10.1021/bi2010448 · Cited by 35
Guda, K., Fink, S. P., Milne, G. L., Molyneaux, N., Ravi, L., Lewis, S. M., Dannenberg, A. J., Montgomery, C. G., Zhang, S., Willis, J. E., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0108 · Cited by 35
Whitlock, E., Williams, S. B., Bu, B., Feightner, A., & Beil, T. L. (2015) · Europe PMC (PubMed Central) · Cited by 35
Scherer, D., Koepl, L., Poole, E. M., Balavarca, Y., Xiao, L., Baron, J. A., Hsu, L., Coghill, A. E., Campbell, P. T., Kleinstein, S. E., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22167 · Cited by 34
Genetics of the Serrated Pathway to Colorectal Cancer
Kedrin, D., & Gala, M. K. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.12 · Cited by 33
Goh, C. H., Goh, H. H., Leong, W. Q., Chew, M. H., Pan, Y. S., Lim, K. H. T., Chew, L. S. T., Tan, I. B. H., Toh, H. C., Tang, C. L., et al. (2014) · PubMed · Cited by 31
Baron, J. A., Senn, S. J., Voelker, M., Lanas, Á., Laurora, I., Thielemann, W., Brückner, A., & McCarthy, D. (2013) · Drugs in R&D · doi:10.1007/s40268-013-0011-y · Cited by 31
Angstadt, A. Y., Hartman, T. J., Lesko, S. M., Muscat, J. E., Zhu, J., Gallagher, C. J., & Lazarus, P. J. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22157 · Cited by 28
Thomas, S., Makar, K. W., Li, L., Zheng, Y., Yang, P., Levy, L., Rudolph, R. Y., Lampe, P. D., Yan, M., Markowitz, S. D., et al. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0161-6 · Cited by 28
Poole, E. M., Hsu, L., Xiao, L., Kulmacz, R. J., Carlson, C. S., Rabinovitch, P. S., Makar, K. W., Potter, J. D., & Ulrich, C. M. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0869 · Cited by 28
Colorectal polyp prevention by daily aspirin use is abrogated among active smokers
Drew, D. A., Goh, G., Mo, A., Grady, J. J., Forouhar, F., Egan, G., Swede, H., Rosenberg, D. W., Stevens, R. G., & Devers, T. J. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0686-1 · Cited by 26
Self-citationLiesenfeld, D. B., Botma, A., Habermann, N., Tóth, R., Weigel, C., Popanda, O., Klika, K. D., Potter, J. D., Lampe, J. W., & Ulrich, C. M. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0697 · Cited by 26
Resler, A. J., Makar, K. W., Heath, L., Whitton, J. A., Potter, J. D., Poole, E. M., Habermann, N., Scherer, D., Duggan, D. J., Wang, H., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu119 · Cited by 22
Rectal Optical Markers for In Vivo Risk Stratification of Premalignant Colorectal Lesions
Radosevich, A. J., Mutyal, N. N., Eshein, A., Nguyen, T., Gould, B. R., Rogers, J. D., Goldberg, M. J., Bianchi, L. K., Yen, E. F., Konda, V. J. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0136 · Cited by 20
Barry, E. L., Mott, L. A., Sandler, R. S., Ahnen, D. J., & Baron, J. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0300 · Cited by 18
Barry, E. L., Poole, E. M., Baron, J. A., Makar, K. W., Mott, L. A., Sandler, R. S., Ahnen, D. J., Bresalier, R. S., McKeown‐Eyssen, G., & Ulrich, C. M. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0088-6 · Cited by 15
Liu, W., Poole, E. M., Ulrich, C. M., & Kulmacz, R. J. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835366f6 · Cited by 10
Aspirin and NSAID Chemoprevention, Gene-Environment Interactions, and Risk of Colorectal Cancer
Wender, R. C. (2015) · JAMA · doi:10.1001/jama.2015.1032 · Cited by 8
Cited by
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
McNeil, J. J., Nelson, M. R., Woods, R. L., Lockery, J. E., Wolfe, R., Reid, C. M., Kirpach, B., Shah, R. C., Ives, D. G., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803955 · Cited by 813
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Li, X., Wenes, M., Romero, P., Huang, S. C.-C., Fendt, S.-M., & Ho, P.-C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0203-7 · Cited by 733
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Park, M., & Hong, J. (2016) · Cells · doi:10.3390/cells5020015 · Cited by 627
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
Cao, Y., Nishihara, R., Wu, K., Wang, M., Ogino, S., Willett, W. C., Spiegelman, D., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.6396 · Cited by 369
Self-citation
Metadata
- Authors
- Drew, D. A., Cao, Y., & Chan, A. T.
- Venue
- Nature Reviews Cancer
- Published
- 2016-02-12
- Volume
- 16
- Issue
- 3
- Pages
- 173-186
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2262329766
- Cited by
- 453
- References
- 147
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.